Gastrointestinal mucositis: The role of MMP-tight junction interactions in tissue injury

Noor Al-Dasooqi; Hannah R. Wardill; Rachel J. Gibson

doi:10.1007/s12253-013-9733-y

Gastrointestinal mucositis: The role of MMP-tight junction interactions in tissue injury

Noor Al-Dasooqi
, Hannah R. Wardill
, Rachel J. Gibson

Research output: Contribution to journal › Review article › peer-review

23 Citations (Scopus)

Abstract

Chemotherapy for cancer causes significant gut toxicity known as mucositis. The pathogenesis of mucositis is ill defined. Recent clinical research guidelines have highlighted epithelial junctional complexes as emerging targets within mucositis research. Given the robust biological evidence linking tight junctions and matrix metalloproteinases, key mediators of mucositis, tight junction proteins have received significant attention. Despite this, the link between tight junctions, matrix metalloproteinases and mucositis development is yet to be established. This critical review therefore aims to describe the role of matrix metalloproteinases in mucositis, and how matrix metalloproteinase- dependent tight junction disruption may contribute to the pathobiology of mucositis.

Original language	English
Pages (from-to)	485-491
Number of pages	7
Journal	Pathology and Oncology Research
Volume	20
Issue number	3
DOIs	https://doi.org/10.1007/s12253-013-9733-y
Publication status	Published - Jul 2014
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s12253-013-9733-y

Cite this

@article{b5e57bda7ced43bd87903d55b24774a1,

title = "Gastrointestinal mucositis: The role of MMP-tight junction interactions in tissue injury",

abstract = "Chemotherapy for cancer causes significant gut toxicity known as mucositis. The pathogenesis of mucositis is ill defined. Recent clinical research guidelines have highlighted epithelial junctional complexes as emerging targets within mucositis research. Given the robust biological evidence linking tight junctions and matrix metalloproteinases, key mediators of mucositis, tight junction proteins have received significant attention. Despite this, the link between tight junctions, matrix metalloproteinases and mucositis development is yet to be established. This critical review therefore aims to describe the role of matrix metalloproteinases in mucositis, and how matrix metalloproteinase- dependent tight junction disruption may contribute to the pathobiology of mucositis.",

keywords = "Gut toxicity, Mucositis, Chemotherapy, Matrix metalloproteinases, Tight junctions",

author = "Noor Al-Dasooqi and Wardill, \{Hannah R.\} and Gibson, \{Rachel J.\}",

year = "2014",

month = jul,

doi = "10.1007/s12253-013-9733-y",

language = "English",

volume = "20",

pages = "485--491",

journal = "Pathology and Oncology Research",

issn = "1219-4956",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Gastrointestinal mucositis

T2 - The role of MMP-tight junction interactions in tissue injury

AU - Al-Dasooqi, Noor

AU - Wardill, Hannah R.

AU - Gibson, Rachel J.

PY - 2014/7

Y1 - 2014/7

N2 - Chemotherapy for cancer causes significant gut toxicity known as mucositis. The pathogenesis of mucositis is ill defined. Recent clinical research guidelines have highlighted epithelial junctional complexes as emerging targets within mucositis research. Given the robust biological evidence linking tight junctions and matrix metalloproteinases, key mediators of mucositis, tight junction proteins have received significant attention. Despite this, the link between tight junctions, matrix metalloproteinases and mucositis development is yet to be established. This critical review therefore aims to describe the role of matrix metalloproteinases in mucositis, and how matrix metalloproteinase- dependent tight junction disruption may contribute to the pathobiology of mucositis.

AB - Chemotherapy for cancer causes significant gut toxicity known as mucositis. The pathogenesis of mucositis is ill defined. Recent clinical research guidelines have highlighted epithelial junctional complexes as emerging targets within mucositis research. Given the robust biological evidence linking tight junctions and matrix metalloproteinases, key mediators of mucositis, tight junction proteins have received significant attention. Despite this, the link between tight junctions, matrix metalloproteinases and mucositis development is yet to be established. This critical review therefore aims to describe the role of matrix metalloproteinases in mucositis, and how matrix metalloproteinase- dependent tight junction disruption may contribute to the pathobiology of mucositis.

KW - Gut toxicity, Mucositis, Chemotherapy

KW - Matrix metalloproteinases

KW - Tight junctions

UR - https://www.scopus.com/pages/publications/84904110854

U2 - 10.1007/s12253-013-9733-y

DO - 10.1007/s12253-013-9733-y

M3 - Review article

C2 - 24424533

AN - SCOPUS:84904110854

SN - 1219-4956

VL - 20

SP - 485

EP - 491

JO - Pathology and Oncology Research

JF - Pathology and Oncology Research

IS - 3

ER -

Gastrointestinal mucositis: The role of MMP-tight junction interactions in tissue injury

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this